Andrew C. Good

Molecular Shape and Medicinal Chemistry: A Perspective

Anthony Nicholls, Georgia B. McGaughey, Robert P. Sheridan et al. · Journal of Medicinal Chemistry · 2010 · 313 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Identification of (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas

Rishi G. Vaswani, Victor Gehling, Les A. Dakin et al. · Journal of Medicinal Chemistry · 2016 · 220 citations · Full text

Medicine, Oncology, Pharmacology +16

Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

Andrew C. Good, Tudor I. Oprea · Journal of Computer-Aided Molecular Design · 2008 · 179 citations

Pharmacy, Bioinformatics, Drug Discovery +6

Structure-activity relationships from molecular similarity matrices

Andrew C. Good, Sung‐Sau So, W. Graham Richards · Journal of Medicinal Chemistry · 1993 · 161 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 118 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12